GlaxoSmithKline makes bold move with £130m Covid-19 investment | Nils Pratley

  • 📰 The Guardian
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 53%

مصر أخبار أخبار

مصر أحدث الأخبار,مصر عناوين

GSK’s share price has been left standing by AstraZeneca’s high-risk success in cancer treatments

Monday’s most important vaccine news was the promising early data from the Oxford University and AstraZeneca coronavirus trial – “robust immune responses” is encouraging. But let’s not overlook other vaccine developments. The industry has been viewed for years as a dull subsector of the pharmaceutical business; now it is a whir of deal-making activity.

 

شكرًا لك على تعليقك. سيتم نشر تعليقك بعد مراجعته.

Bold? With Lord Backsheesh Of Durham At Barnham Castle?

Fuck your poison dart. We know the shite that is in it. The people are waking up!

لقد قمنا بتلخيص هذا الخبر حتى تتمكن من قراءته بسرعة. إذا كنت مهتمًا بالأخبار، يمكنك قراءة النص الكامل هنا. اقرأ أكثر:

 /  🏆 84. in EG

مصر أحدث الأخبار, مصر عناوين